Facebook Instagram Linkedin Youtube
Home Tags KL1333

Tag: KL1333

Abliva new approach to mitochondrial diseases

A new approach to mitochondrial diseases

Abliva secures financing

Abliva secures funding to advance KL1333 into phase II/III

BioStock intervjuar Abliavs vd Ellen Donnelly via link

Abliva on the 200 MSEK financing round

Abliva celebrates FDA IND approval

Celebrating IND approval Abliva eyes next step with KL1333

Abliva

Abliva is ready for a pivotal year

Abliva

Abliva on the IND-approval from FDA

FDA godkänner Ablivas IND-ansökan för KL1333

FDA approves Abliva’s IND-application for KL1333

Abliva NV354 Leigh syndromE

Abliva’s NV354 targets fatal paediatric disease

mitokondriell sjukdom

Raising awareness of mitochondrial diseases

Mikroskop

Q2 report shows strong clinical development for Abliva

12Page 1 of 2
© BioStock 2025